Clinical Trial Update: Romosozumab and Denosumab, Alone or Combined, in Postmenopausal Osteoporosis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating romosozumab and denosumab, alone or in combination, for postmenopausal osteoporosis; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis

Drugs mentioned

• Denosumab (denosumab)
• Romosozumab (romosozumab)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Osteoporosis | Phase 4 | Status: RECRUITING